动态血清磷水平对脓毒症患者预后的预测价值
该回顾性研究纳入2016年1月至2017年6月常州市第二人民医院ICU收治的85例脓毒症患者(年龄≥18岁,ICU停留>72小时),按28天结局分为生存组60例和死亡组25例(病死率29.4%)。死亡组APACHE II评分显著高于生存组(22.28±3.98 vs. 16.05±5.44,P<0.01),血管活性药物使用率显著更高[64.0%(16/25)vs. 31.7%(19/60),P<0.01]。生存组血清磷随时间升高,死亡组呈下降趋势,第3、5、7天死亡组血清磷均显著低于生存组(均P<0.01)。第7天血清磷预测28天死亡的AUC为0.945,以1.01 mmol/L为界值敏感度91.7%、特异度84.0%。第7天血清磷>1.01 mmol/L者28天生存率93.2%(55/59)显著高于≤1.01 mmol/L者22.7%(5/22)。
要点
- 脓毒症患者血清磷持续下降提示预后不良;第7天血清磷是评估28天预后的重要指标之一。
- 第7天血清磷预测28天死亡AUC为0.945,高于APACHE II评分的0.813(均P<0.01)。
- 第7天血清磷以1.01 mmol/L为界值预测28天死亡:敏感度91.7%、特异度84.0%,阳性似然比5.73、阴性似然比0.10。
- 第7天血清磷>1.01 mmol/L者28天生存率93.2%(55/59)vs. ≤1.01 mmol/L者22.7%(5/22),χ²=49.697,P=0.000。
- 死亡组APACHE II评分22.28±3.98 vs. 生存组16.05±5.44(P<0.01),血管活性药物使用率64.0%(16/25)vs. 31.7%(19/60)(P<0.01)。
适用人群与场景
- 2016年1月至2017年6月常州市第二人民医院ICU收治的脓毒症患者,年龄≥18岁,ICU停留时间>72小时。
- 按28天结局分为生存组(60例)和死亡组(25例)。
诊断标准与关键阈值
- 依据第7天血清磷1.01 mmol/L为界值评估28天死亡预测价值。
- 依据不同时间点血清磷界值将患者分组行Kaplan-Meier生存分析。
研究设计与关键结果
- 回顾性研究纳入85例脓毒症患者,死亡组25例,病死率29.4%。
- 死亡组APACHE II评分显著高于生存组(22.28±3.98 vs. 16.05±5.44,P<0.01);血管活性药物使用率显著高于生存组[64.0%(16/25)vs. 31.7%(19/60),P<0.01];两组有创机械通气时长和ICU停留时间无显著差异。
- 生存组血清磷随治疗时间升高,死亡组呈下降趋势;第3、5、7天死亡组血清磷均显著低于生存组(mmol/L:第3天0.90±0.24 vs. 1.05±0.19,第5天0.96±0.16 vs. 1.11±0.17,第7天0.83±0.19 vs. 1.21±0.14,均P<0.01)。
- ROC曲线分析:APACHE II评分和第7天血清磷均可显著预测28天死亡,AUC分别为0.813和0.945(均P<0.01);第3天和第5天血清磷AUC分别为0.692和0.745(均P<0.01)。
- 第7天血清磷以1.01 mmol/L为界值预测28天死亡:敏感度91.7%、特异度84.0%,阳性似然比5.73、阴性似然比0.10。
- Kaplan-Meier生存分析:ICU入住不同时间点血清磷高于界值者28天生存率显著更高、生存时间显著更长;第7天血清磷>1.01 mmol/L者 vs. ≤1.01 mmol/L者28天生存率93.2%(55/59)vs. 22.7%(5/22),χ²=49.697,P=0.000;生存期(天)27.1±3.6 vs. 19.8±7.8,t=4.768,P=0.000。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清磷持续下降提示预后不良,第7天血清磷水平是评估脓毒症患者预后的最重要指标之一。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the predictive value of dynamic serum phosphorus levels in the evaluation of prognosis in patients with sepsis.
METHODS: A retrospective study was conducted. The septic patients admitted to intensive care unit (ICU) of the Second People's Hospital of Changzhou from January 2016 to June 2017 were enrolled, who were ≥18 years old and whose length of ICU stay > 72 hours. These patients were divided into survival group and death group according to 28-day outcome. The general information, the acute physiology and chronic health evaluation II (APACHE II) score within 24 hours of ICU admission, the serum phosphorus at 1, 3, 5, 7 days after admission were collected. Receiver operating characteristic curve (ROC) was plotted according to the dynamic serum phosphorus levels and APACHE II score for evaluating the predictive value of 28-day prognosis. Kaplan-Meier survival curve was used to analyze the 28-day cumulative survival rate between two groups of patients, who were divided according to the corresponding time of the serum phosphorus cut-off value.
RESULTS: (1) Eighty-five patients with sepsis were enrolled, among whom 25 cases were in the death group and the mortality was 29.4%. APACHE II score in the death group was significantly higher than that in the survival group (22.28±3.98 vs. 16.05±5.44, P < 0.01), the rate of using vasoactive drugs was significantly higher than that in the survival group [64.0% (16/25) vs. 31.7% (19/60), P < 0.01], but there was no significant difference in the length of invasive mechanical ventilation and ICU stay between two groups. (2) The level of serum phosphorus was increased in survival group along with time of the treatment, and the death group showed a downward trend. The levels of serum phosphorus at 3, 5, 7 days after admission to ICU in death group were significantly lower than those in survival group (mmol/L: 0.90±0.24 vs. 1.05±0.19 at 3 days, 0.96±0.16 vs. 1.11±0.17 at 5 days, 0.83±0.19 vs. 1.21±0.14 at 7 days, all P < 0.01).(3) ROC curve analysis showed that APACHE II score and serum phosphorus level on the 7th day could significantly predict 28-day mortality in patients with sepsis, and the areas under ROC curve (AUC) of them were 0.813 and 0.945 respectively (both P < 0.01). The AUC of serum phosphorus level on the 3rd day and 5th day were 0.692 and 0.745 respectively (both P < 0.01). Based on serum phosphorus cut-off value 1.01 mmol/L on the 7th day to evaluate the predictive value of 28-day mortality, the sensitivity was 91.7%, the specificity was 84.0%, the positive and negative likelihood ratios were 5.73 and 0.10 respectively. (4) Kaplan-Meier survival analysis showed that the 28-day survival rate was significantly higher and the length of survival was significantly longer if the serum phosphorus were higher than the cut-off value at different time points of ICU admission. The 28-day survival rate was significantly higher and the length of survival was significantly longer in the patients with serum phosphorus > 1.01 mmol/L than those serum phosphorus ≤ 1.01 mmol/L on the 7th day [28-day survival rate: 93.2% (55/59) vs. 22.7% (5/22), χ 2 = 49.697, P = 0.000; survival period (days): 27.1±3.6 vs. 19.8±7.8, t = 4.768, P = 0.000].
CONCLUSIONS: The continuous decline of serum phosphorus indicates poor prognosis, and the serum phosphorus level on the 7th day is one of the most important indicator to evaluate the prognosis of patients with sepsis.
参考来源
- Yang Q, Zhou Y, Yu J, et al. [Predictive value of dynamic serum phosphorus levels in the prognosis of patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 29216939. doi:10.3760/cma.j.issn.2095-4352.2017.12.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。